BACKGROUND: Emerging data suggest that obesity increases the risk of aggressive prostate cancer (PC), but the mechanisms underlying this relationship remain to be fully elucidated. Oxidative stress (OS) is a key process in the development and progression of PC. Adiponectin, an adipocyte-specific hormone, circulates at relatively high levels in healthy humans, but at reduced levels in obese subjects. Moreover, case-control studies also document lower levels of serum adiponectin in PC patients compared with healthy individuals.
Introduction
Cancer initiation and progression are influenced by intrinsic tumor-dependent factors. However, host factors can influence the individual environment in which each specific tumor grows and its potential to progress. Obesity, a classic host factor, is known to increase the risk of prostate cancer (PC). Findings from large prospective cohort trials indicate that men with higher body mass index are more likely to be diagnosed with aggressive PC and are at higher risk of PC-related death compared with men having normal body mass index. [1] [2] [3] [4] Reasons for these findings are likely multi-factorial and include detection bias (lower PSA levels and larger prostates 5 and difficult digital rectal examination in overweight patients), which leads to delayed diagnosis. Other reasons may relate to an unfavorable pro-proliferative hormonal profile with higher insulin and insulin growth factor levels 5 and a poor diet with excess calories, 5 dietary fat 6 and refined carbohydrate intake. 7 The adipose tissue is the largest endocrine organ in mammals, producing a vast number of hormones, collectively referred to as adipokines. The blood levels of one of these hormones, adiponectin, are inversely related to body weight, and are reduced in obese patients. 8, 9 Several case-control studies have documented that lower levels of adiponectin are associated with increased incidence and aggressiveness of PC. [10] [11] [12] [13] [14] However, the mechanisms responsible for the tumorsuppressive effects of adiponectin are not clear.
Oxidative stress (OS) triggers a host of pro-carcinogenic processes and is a key event in the initiation, development and progression of PC. It is caused by an imbalance between the production of reactive oxygen species (ROS) and their detoxification by enzymes, such as catalase and manganese superoxide dismutase (MnSOD). OS related to age, 15 inflammation and nutrition, 16 as well as exposure to androgens, 17 leads to pro-carcinogenic events, in particular accumulation of oxidative DNA damage. Likewise, it has been suggested that compared with normal subjects or patients with BPH, PC patients have a systemic imbalance in their OS/anti-oxidant status. 18 There are two major sources of cellular ROS. The main source is the mitochondria, which is coupled to fatty acid oxidation and the family of NADPH oxidase (NOX) enzymes that transport electrons across biological membranes to generate superoxide O 2 Á À by the reduction of oxygen. 19 Another cellular source of ROS, albeit to a lesser extent, are the peroxisomes. Owing to the presence and action of xanthine oxidase, peroxisomal ROS consist predominantly of superoxide anion radicals. 20 Adiponectin has been shown to activate 5 0 AMP-activated protein kinase (AMPK). [21] [22] [23] Activated AMPK phosphorylates and inactivates the main regulator of mitochondrial fatty acid oxidation acetyl-CoA carboxylase (ACC). As ACC in turn converts acetyl-CoA to malonyl-CoA, an inhibitor of carnitine palmitoyltransferase 1, the ratelimiting enzyme for mitochondrial fatty acid oxidation, adiponectin is expected to stimulate mitochondrial fatty acid oxidation and hence mitochondrial production of ROS. The main cellular detoxification mechanism of ROS is enzymatic. SOD is considered to be the primary defense mechanism, as it converts superoxide, a highly reactive ROS and a strong initiator of oxidative chain reaction, to hydrogen peroxide. Hydrogen peroxide must then be reduced to water by catalase in order to prevent the formation of hydroxyl radicals.
To delineate the mechanisms responsible for the tumor-suppressive effects of adiponectin in PC, we investigated whether adiponectin, a hormone that has been shown to circulate at lower levels in obese and PC patients, has a protective role against the generation of OS in PC cells. We thus focused on the effects of adiponectin on production of the superoxide anion and expression of NOX, the major source of ROS in PC cells 24 on the one hand, and on the expression and activity of SOD and catalase on the other.
Materials and methods

Cell lines
Human prostate adenocarcinoma DU-145 and 22Rv1 cell lines were obtained from ATCC (Manassas, VA, USA). The DU-145 cell line was originally derived from a brain metastasis from a prostate adenocarcinoma patient. 25 The cells are androgen-independent, do not express PSA and represent an aggressive PC cell line, whereas 22Rv1 cells were derived from a PC xenograft that relapsed during androgen withdrawal. 22Rv1 cells are considered less aggressive, are androgen-responsive and express PSA. 26 Cells were propagated in RPMI 1640 medium supplemented with 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1.0 mM sodium pyruvate (SigmaAldrich, Oakville, Ontario, Canada) and 10% fetal bovine serum (Invitrogen, Burlington, Ontario, Canada). Cells were cultured at 37 1C in a humidified atmosphere containing 5% CO 2 .
Adiponectin treatment
Full-length human recombinant adiponectin (BioVendor, Candler, NC, USA) was used to treat human PC cell lines. Optimization experiments were conducted to determine the effective concentrations of adiponectin for each cell line. To avoid interference of adiponectin present in fetal bovine serum, all experiments were conducted in serum-free RPMI 1640 or Opti-MEM medium (Invitrogen) following a minimum of 24 h of culture in serum-free medium.
Superoxide anion production PC cells were seeded at 40 000 cells per well in a 96-well plate. After culture for 24 h in serum-free medium, adiponectin was added at 20 or 40 mg ml -1 in Opti-MEM medium. After another 24 h, intracellular superoxide anion production was detected by the nitroblue tetrazolium (NBT) assay (Sigma-Aldrich). Upon reduction, the yellow water-soluble NBT changed to dark-blue insoluble formazan. Cells were incubated for 90 min at 37 1C and 5% CO 2 in phosphate-buffered saline (PBS) containing 0.2% NBT. Wells were washed twice with PBS and formazan was dissolved in 60 ml 2 M KOH and 70 ml DMSO by sonication for 10 min. Absorbance was measured using a microplate reader at 620 nm. 27, 28 The results were normalized to cell number using the WST-1 assay (Roche Diagnostics, Laval, Quebec, Canada) and were expressed as percentage of untreated control.
Quantitative reverse transcriptase-PCR
Human 22Rv1 and DU-145 PC cells were treated with 20 mg ml -1 adiponectin for 24 h. Total RNA was isolated using the RNeasy mini-kit (Qiagen, Mississauga, Ontario, Canada). To determine the relative expression, RNA was reverse-transcribed using 200 ng of total RNA in the presence of Superscript II RT (200 U, Invitrogen) using oligo(dT) 12À18 . Complementary DNA was amplified in a total volume of 50 ml using the iQ Sybr Green kit (BioRad Laboratories, Mississauga, Ontario, Canada) in Tris-HCl (20 mM) and 50 mmol KCl (pH 8.3), dNTPs (0.2 mM), 1.2 U Taq DNA polymerase (BioRad Laboratories) and gene-specific primers (500 nmol) for NOX2 and NOX4. The sequences for the NOX2 and NOX4 primer pairs were obtained from Vaquero et al. 29 The reactions were carried out in a Mini-Opticon thermal cycler (BioRad Laboratories). PCR was started by a 3-min denaturation at 95 1C, followed by 35 cycles of 25-s annealing at 62 1C, 25-s extension at 72 1C and 30-s denaturation at 94 1C.
In each PCR run, 500 nmol of primers for b-actin were used as internal control as previously described. 30 The 2 ÀDDCt method was used to calculate relative expression levels.
Anti-oxidant assays
Human PC cells were seeded at 5 Â 10 5 cells per well in a six-well plate. After adiponectin treatment, the cells were washed twice with PBS. The cells were collected in 1 ml ice-cold PBS by scraping, lysed by sonication, followed by centrifugation at 10 000 g for 15 min. The protein concentration in the supernatant was determined using the DC protein concentration determination kit (BioRad Laboratories). Total anti-oxidant potential in lysates (20 mg) was measured using a colorimetric quantitative assay kit (OxisResearch, Adiponectin and oxidative stress J-P Lu et al Beverly Hills, CA, USA), which is based on the reduction of Cu 2 þ to Cu þ contributed by all anti-oxidants present. The chromogenic reagent selectively forms a 2:1 complex with Cu þ , which has a maximum absorbance at 450 nm. Uric acid was used to obtain a calibration curve. The anti-oxidant potential was calculated as mM uric acid equivalents per ml.
Catalase activity in the cell lysates (10 mg) was determined using a commercially available kit, following the manufacturer's instructions (Cayman Chemicals, Ann Arbor, MI, USA). The catalase assay is based on the reaction with methanol in the presence of H 2 O 2 . The formaldehyde produced was measured spectrophotometrically using the chromogen purpald, which upon oxidation changes from colorless to a purple color. The catalase activity was determined using a standard curve of formaldehyde.
Western blot analysis
PC cells seeded at 5 Â 10 5 cells per well in the six-well plate were treated with adiponectin for 24 h. The cells were washed with PBS, collected and centrifuged at 450 g for 5 min at 4 1C. The pellet was resuspended in NP40 lysis buffer (50 mmol l -1 Tris (pH 7.6), 150 mmol l -1 NaCl, 1% NP40, 10% glycerol, proteinase inhibitor cocktail (Sigma-Aldrich)) for 30 min at 4 1C. The lysates were centrifuged at 10 000 g for 10 min at 4 1C, the supernatant was collected and the protein concentration determined. Cell lysate (20 mg) was resolved by 12% SDS-polyacrylamide gel electrophoresis and proteins were transferred onto a polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA). After blocking non-specific binding sites with TBST containing 5% skim milk, the membrane was incubated with the primary antibody (1:1000, rabbit anti-AdipoR1, anti-AdipoR2 (Abbiotech, San Diego, CA, USA)), rabbit anti-phospho (Ser79)-acetyl-CoA-carboxylase, rabbit anti-AMPK or anti-phospho (Thr172)-AMPK (Cell Signaling Technology, Danvers, MA, USA), rabbit anti-catalase (Millipore) and rabbit anti-MnSOD (Abcam, Cambridge, MA, USA). The secondary antibody conjugated with horseradish peroxidase (1:3000; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) was used in conjunction with chemiluminescence detection (Pierce SuperSignal Pico Chemiluminescent, Fisher Scientific, Ottawa, Ontario, Canada). An antibody specific for b-actin (1:1000, Sigma-Aldrich) served as internal control. The relative amount of MnSOD or catalase protein expression was normalized to the amount of actin using densitometry.
Statistical analysis
Statistical analysis was performed using STATA SE 11.0 (College Station, TX, USA). Normality was confirmed by the Shapiro-Wilk test. The normally distributed data were analyzed using a one-way analysis of variance test. The data that were not normally distributed (superoxide anion production results, protein expression data, and the catalase activity data for the 22Rv1 cell line) were analyzed by the Mann-Whitney U-test. The DDCt values were analyzed using a non-parametric Wilcoxon-signed rank test. A P-value o0.05 was regarded as significant. P-values o1 Â 10 À4 are given as Po0.0001.
Results
We measured the generation of OS and the expression and activity of several enzymes involved in the detoxification of ROS in two human prostate adenocarcinoma cell lines, 22Rv1 and DU-145. We first determined the production of superoxide anion after adiponectin treatment by the reduction of NBT. Treatment of human 22Rv1 PC cells with full-length adiponectin decreased the generation of superoxide in a dose-dependent manner by 43% and 46% at 20 and 40 mg ml -1 adiponectin, respectively (Figure 1a) . Similarly, in DU-145 cells, adiponectin also decreased the generation of superoxide anion by 22% and 32% at 20 and 40 mg ml -1 adiponectin, respectively (Figure 1b) . The inhibition reached statistical significance at the concentration of 40 mg ml -1 for both 22Rv1 and DU-145 cells as shown in Figure 1 (P ¼ 0.02 and 0.01, respectively). As an indirect measure of superoxide anion generation, we also determined the transcript levels of the NOX enzymes, NOX2 and NOX4, after treatment with full-length adiponectin for 24 h by quantitative reverse transcriptase-PCR. The generation of mitochondrial ROS is coupled to fatty acid oxidation. The family of NOX enzymes transfers electrons from NADPH across biological membranes to generate superoxide anion. Interestingly, treatment with adiponectin induced a significant increase in the transcript levels of Figure 3a shows that both PC cell lines express AdipoR1 and AdipoR2, the receptors through which adiponectin's signal is transduced. 31, 32 A well-characterized molecular pathway in adiponectin signaling in PC cells is through the activation (phosphorylation) of AMPK. 23 Using human 22Rv1 PC cells, we confirmed that full-length adiponectin was able to phosphorylate and activate AMPK, without affecting the amount of AMPK. At 20 mg ml -1 adiponectin, P-AMPK, normalized for the expression of b-actin, increased 2.2-fold compared with the levels found in untreated control cells. The activation of AMPK consequently led to an almost fourfold increase in the phosphorylation of its downstream target ACC (Figure 3b) , which is inhibitory to its activity.
Concomitantly, we determined the total cellular antioxidative potential after adiponectin treatment by measuring the reducing potential of all anti-oxidants present in the sonicated lysate samples from both PC cell lines. Adiponectin significantly increased the anti-oxidative potential in a dose-dependent manner in both 22Rv1 and DU-145 cells (Po0.0001) (Figure 4) . Similarly, we examined whether adiponectin treatment affected the protein expression and activity of catalase, one of the key anti-oxidative enzymes involved in the detoxification of hydrogen peroxide. Indeed, treatment with adiponectin significantly and dose-dependently increased the expression of catalase, by approximately twofold at 40 mg ml -1 adiponectin, in both cell lines (Figures 5a-c) . This translated into a significantly increased activity of the enzyme, as measured spectrophotometrically against formaldehyde as a standard (Figures 5d and e) . Furthermore, the protein expression of MnSOD, an important enzyme in the mitochondrial matrix that dismutates superoxide anion to generate hydrogen peroxide, was also found to be significantly elevated in both PC cell lines after treatment with adiponectin (Po0.05) (Figure 6 ). Total RNA was isolated, cDNA was reverse-transcribed using oligo-dT primers and RT-PCR was performed using NOX-specific primers. The difference in threshold cycle (DCt) between the gene of interest and the internal control (b-actin) was used to calculate the relative fold expression (2 ÀDDCt ±s.d.) compared with the expression in corresponding untreated control cells. All experiments were carried out at least three times independently in duplicate. *Statistically significant differences were determined using the Wilcoxon signedrank test (Po0.05). adiponectin for 24 h in serum-free medium and the total antioxidant potential was measured in (a) 22Rv1 and (b) DU-145 cell lysates. Data represent mean±s.d. from at least two independent experiments carried out in triplicate. Statistically significant differences as determined using a one-way analysis of variance are indicated by the P-values.
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Discussion
We investigated the effects of adiponectin on OS in human PC cells. OS caused by an imbalance between the production of ROS and their detoxification leads to procarcinogenic events. On the one hand, we measured both the production of superoxide anion and the expression of the main two enzymes responsible for the production of superoxide anion after adiponectin treatment. Treatment of 22Rv1 and DU-145 PC cells with adiponectin decreased the generation of superoxide in a dosedependent manner (Figure 1) . The transcript levels of NOX2 and NOX4 after treatment with adiponectin were signficantly induced in both DU-145 and 22Rv1 PC cells (Figure 2) , suggesting that the generation of superoxide anion in 22Rv1 and DU-145 is mainly through a pathway other than NOX2 and NOX4. Protein expression of NOX2 and NOX4 was not undertaken because of a lack of suitable antibodies.
On the other hand, we also determined the total cellular anti-oxidative potential after adiponectin treatment by measuring the reducing potential of all antioxidants present in the lysate samples from both PC cell lines. Adiponectin increased the anti-oxidative potential in a dose-dependent manner (Figure 4) , explaining in part the larger decrease in superoxide anion levels ( Figure 1 ) despite elevated transcript levels of NOX2 and NOX4 (Figure 2) . Moreover, adiponectin also Adiponectin and oxidative stress J-P Lu et al induced a significant elevation in the protein expression of MnSOD ( Figure 6 ) and the activity and protein expression of catalase in both cell lines ( Figure 5) . Overall, the results of this in vitro study indicate that adiponectin exerts anti-oxidative effects in PC cells. We demonstrate that these effects of adiponectin are dose-dependent and are mediated by the induction of anti-oxidative enzymatic defense mechanisms. It is reasonable to believe that adiponectin actually stimulates the production of ROS. Mitochondrial ROS is coupled to fatty acid oxidation and the family of NOX enzymes that transport electrons across biological membranes to generate superoxide anion by the reduction of oxygen. 33 Adiponectin treatment is expected to stimulate mitochondrial fatty acid oxidation and hence mitochondrial production of ROS through its phosphorylation and activation of AMPK. [21] [22] [23] Activated AMPK inactivates ACC through phosphorylation on serine 79. ACC converts acetyl-CoA to malonyl-CoA, which in turn inhibits the rate-limiting enzyme for mitochondrial fatty acid oxidation, carnitine palmitoyltransferase 1. As shown, adiponectin also increases the mRNA expression of NOX2 and NOX4 enzymes (Figure 2) . Thus, although adiponectin may increase the generation of ROS, through both inhibition of ACC ( Figure 3 ) and increase in NOX expression (Figure 2) , the end effect is that the levels of OS in PC cells are suppressed (Figure 1 ) through the augmentation of their anti-oxidative capacity (Figures 4,  5, and 6) .
OS elicits pro-carcinogenic events in initiation, development and progression of PC. One limitation of our study is the use of human PC cell lines, which would suggest that adiponectin has a role in PC progression rather than in cancer initiation. To investigate the events during initiation, normal prostate epithelial cells would appear to be a better choice. However, the available models have significant limitations. PNT1A, human adult prostate epithelial cells immortalized with SV40 large-T antigen, demonstrate c-myc gene amplifications and therefore do not truly represent normal cells. Primary prostate epithelial cells have very limited and unpredictable growth capacity in culture and are not suitable for carrying out the experiments.
OS is a facilitating event in the development of PC. Accordingly, cells under OS may manifest continuous genetic alterations that can lead to carcinogenesis. 34 In particular, the aging prostate, which is exposed to androgenic, inflammatory and nutritional OS-generating insults, 35 often suffers from inherent insufficient capacity to neutralize OS in men prone to develop PC. For example, inactivation of the pi-class glutathione S-transferase gene GSTP1 by promoter hypermethylation appears to uniformly accompany human prostatic carcinogenesis. 36 Thus, by increasing the expression and activity of catalase and MnSOD, adiponectin may supplement the cellular anti-oxidative capacity to overcome the accumulation of ROS mediated by its own effects (mitochondrial respiration and NOX activity) as well as by processes such as aging, inflammation and nutritional factors that link OS generation and development of PC. Our study, which shows that adiponectin increased the cellular anti-oxidant potential in vitro, may also have implications for the treatment of PC. As part of their primary mode of action, radiation and many Figure 6 Adiponectin increases the protein expression of manganese superoxide dismutase (MnSOD). Human prostate cancer cells were treated with 0, 20 or 40 mg ml -1 adiponectin for 24 h in serum-free medium and MnSOD expression was determined by western blot analysis using an antibody specific for MnSOD (a). MnSOD protein expression data from three experiments were quantified and normalized for the expression of b-actin by densitometric analysis. The mean relative expression±s.d. is shown in (b) for 22Rv1, and in (c) for DU-145 cells. Statistically significant differences as determined using a two-tailed Mann-Whitney U-test are indicated by the P-values.
Adiponectin and oxidative stress J-P Lu et al chemotherapy agents induce OS, directly or indirectly, resulting in apoptosis. One could thus hypothesize that patients with lower serum adiponectin levels have higher susceptibilities to such treatments when compared with patients with higher serum adiponectin levels, a hypothesis that needs to be examined in prospective randomized clinical trials.
The mechanism implied by the results of our study may explain the link between hypo-adiponectinemia and PC that was demonstrated in case-control studies. 10, 11, 14 Maximizing adiponectin signaling appears logical as a translational possibility in PC. Unfortunately, treatment with adiponectin per se is impractical, as it has a short half-life, is present at high circulating levels, and largescale production of the native forms of full-length adiponectin with all post-translational modifications is a difficult task. 37 However, several other strategies to maximize adiponectin signaling are currently under investigation. Moreover, whether obese patients who generally have lower circulating levels of adiponectin also suffer from higher levels of prostatic OS remains to be determined. Nevertheless, the results of this study propose a potential link between obesity and prostatic OS, portraying a possible mechanistic link between obesity and PC.
